GMR-GAL4 virgin females are crossed to each UAS-RNAi candidate line and to controls. Conditions: GMR-GAL4 x UAS-mCherry-RNAi (driver-only/nonspecific RNAi control), GMR-GAL4 x w1118 (background), and GMR-GAL4 x each candidate UAS-RNAi. Crosses raised at 25 C and 29 C (higher GAL4 activity) in parallel. n>=15 individual eyes/genotype/temperature, from >=3 independent crosses. Eyes scored blinded. Order of imaging randomized. Each candidate is tested with >=2 independent RNAi lines to control for off-target effects.
BSL-1 / arthropod containment; freeze or morgue all flies before disposal, never release transgenics. CO2 anesthesia requires ventilation. SEM prep hazards: glutaraldehyde is a sensitizer and respiratory irritant — use in a fume hood with nitrile gloves and goggles; critical-point dryer uses high-pressure liquid CO2 (trained operators only); sputter coater handling per facility SOP. Ethanol dehydration series is flammable. Dispose glutaraldehyde and gold/heavy-metal waste through hazardous-waste streams.
Negative/nonspecific control: GMR-GAL4 x UAS-mCherry-RNAi controls for the general effect of expressing a hairpin and for any RNAi-machinery load on the eye. Background control: GMR-GAL4 x w1118 establishes the baseline sensitized rough-eye severity. Driver-only and UAS-only parental lines (uncrossed) confirm neither alone produces the phenotype. Off-target control: two independent, non-overlapping RNAi lines per candidate; concordant modification is required to call a hit. Temperature pairing (25/29 C) controls for GAL4 dosage sensitivity.
The driver-only/nonspecific control defines a stable baseline rough-eye severity (e.g., a characteristic reduced count of regular pseudopupils). Enhancers should significantly reduce regular ommatidia/pseudopupil counts and increase fusion; suppressors should increase regular counts toward wild-type. Effects should be larger at 29 C. True hits show concordant direction across both independent RNAi lines. Effect sizes are reported as mean change in countable ommatidia per field with 95% CI.
To run a quantitative, blinded GAL4/UAS-RNAi enhancer/suppressor screen in the GMR-GAL4 sensitized Drosophila eye, scoring modification by pseudopupil optical-neutralization counts and ommatidial morphometrics, with two-independent-RNAi-line concordance and temperature pairing to control off-target and dosage effects.
Independent: candidate gene knockdown (which UAS-RNAi line) and rearing temperature (25 vs 29 C). Dependent: countable regular pseudopupils per field, ommatidial regularity index, and disorder/fusion frequency. Controlled: driver (GMR-GAL4), F1 age at scoring (1-3 d), fly density, food batch, imaging field size, scorer blinding, and number of independent crosses.
Knockdown of genuine genetic modifiers via UAS-RNAi in the GMR-GAL4 sensitized eye will significantly alter ommatidial regularity and pseudopupil count relative to a UAS-RNAi control crossed to the same driver, with enhancers reducing and suppressors restoring the number of countable regular ommatidia.
Pseudopupil and ommatidial counts are recorded per eye and averaged per genotype/temperature. A regularity index (e.g., coefficient of variation of ommatidial spacing from imprint/SEM images) is computed in Fiji using a custom macro. Counts are normalized to the driver-only nonspecific-RNAi control run on the same day to correct for batch/temperature drift. Candidate hits are ranked by normalized effect size and concordance across the two RNAi lines.
Per-eye counts are compared between each candidate and the nonspecific-RNAi control by one-way ANOVA with Dunnett's post hoc (controls as reference) at alpha = 0.05, run separately per temperature. A false-discovery-rate (Benjamini-Hochberg) correction is applied across the full candidate set. With n>=15 eyes/genotype, the design has >80% power to detect a 20% change in regular ommatidial count (effect size d ~ 0.9). A two-RNAi-line concordance filter further controls false positives.